Zika Virus

The Zika Virus, a mosquito-borne flavivirus, gained international attention due to a series of outbreaks in recent years. First identified in Uganda in 1947, the virus remained relatively obscure until the 2015 epidemic in the Americas. One of the major concerns associated with Zika is its impact on pregnancy. The virus is linked to congenital Zika syndrome, which includes severe birth defects such as microcephaly. Pregnant women infected with Zika face an increased risk of complications, prompting travel advisories and public health measures to prevent transmission. The Aedes mosquitoes, particularly Aedes aegypti, are the primary vectors for Zika Virus transmission. The virus can also be sexually transmitted, posing challenges for disease control and prevention. Efforts to combat Zika involve vector control strategies, public health campaigns to raise awareness, and research to develop vaccines and antiviral treatments. Global collaboration is crucial in addressing the Zika Virus. Research institutions, governments, and international organizations work together to understand the virus, develop diagnostic tools, and implement preventive measures. By integrating expertise from various fields, such as virology, entomology, and reproductive health, the global community aims to mitigate the impact of Zika on public health and safeguard vulnerable populations.

Related Sessions